Studies in vitro and in vivo using TGF-β1 and TGFB1I1 shRNA demonstrated that TGFB1I1 is required for TGF-β stimulated EMT that contributes to malignant progression of astrocytomas. The gene discussed is TGFB1I1; the disease is astrocytoma (excluding glioblastoma).